Drug intelligence / Profile preview

Selen-Activ

Development stage
Unknown
Lead developer
Diod
Modality
Small Molecules
Administration
Oral
01

Overview

Selen-Activ is a dietary supplement developed by the Diod Plant of Environmental Technology and Eco-Nutrition in Russia, in collaboration with specialists from the Medical Radiological Scientific Center of the Russian Academy of Medical Sciences. The product contains Selexen (selenoxanthene), a unique organic compound where selenium is bound to a xanthene biomolecule, combined with Vitamin C (ascorbic acid). It is designed to provide adaptive antioxidant support: when the body is deficient in selenium, the compound releases selenium to activate selenium-dependent antioxidant enzymes such as glutathione peroxidase; when selenium levels are sufficient, the molecule acts as an independent antioxidant to neutralize free radicals. It is primarily indicated for addressing selenium deficiency, supporting cardiovascular health, and normalizing cholesterol metabolism.

Brand names
Selen-ActivСелен-Актив
Other names
Selexenselenoxantheneселеноксантен
02

Targets

GPX4 (Glutathione peroxidase 4)

Beyond the preview

Go deeper on Selen-Activ.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Selen-Activ.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call